Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Non-Current Assets (2020 - 2025)

Rapid Micro Biosystems' Non-Current Assets history spans 6 years, with the latest figure at $13.7 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 20.68% to $13.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $59.8 million, a 18.73% decrease, with the full-year FY2025 number at $13.7 million, down 20.68% from a year prior.
  • Non-Current Assets hit $13.7 million in Q4 2025 for Rapid Micro Biosystems, down from $14.5 million in the prior quarter.
  • Over the last five years, Non-Current Assets for RPID hit a ceiling of $57.3 million in Q3 2022 and a floor of $10.3 million in Q3 2021.
  • Historically, Non-Current Assets has averaged $26.6 million across 5 years, with a median of $19.6 million in 2024.
  • Biggest five-year swings in Non-Current Assets: soared 458.59% in 2022 and later crashed 55.76% in 2023.
  • Tracing RPID's Non-Current Assets over 5 years: stood at $23.0 million in 2021, then soared by 125.97% to $52.1 million in 2022, then crashed by 55.76% to $23.0 million in 2023, then dropped by 25.11% to $17.3 million in 2024, then dropped by 20.68% to $13.7 million in 2025.
  • Business Quant data shows Non-Current Assets for RPID at $13.7 million in Q4 2025, $14.5 million in Q3 2025, and $15.4 million in Q2 2025.